BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND TTL, 2410003M22Rik, 150465, ENSG00000114999, MGC46235, Q8NG68 AND Treatment
7 results:

  • 1. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
    Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD
    Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVAttl Pro 3 Study.
    Martín-Salvago MD; Sancho M; López-García MÁ; Cano Jiménez A; Pérez-Luque A; Alfaro L; Vieites B
    Breast Cancer Res Treat; 2023 Jul; 200(2):203-215. PubMed ID: 37219637
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVAttl study.
    Vieites B; López-García MÁ; Martín-Salvago MD; Ramirez-Tortosa CL; Rezola R; Sancho M; López-Vilaró L; Villardell F; Burgués O; Fernández-Rodriguez B; Alfaro L; Peg V
    Clin Transl Oncol; 2021 Jul; 23(7):1377-1385. PubMed ID: 33517542
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients.
    Piñero-Madrona A; Ripoll-Orts F; Sánchez-Méndez JI; Chaves-Benito A; Gómez-de la Bárcena MR; Calatrava-Fons A; Menjón-Beltrán S; Peg-Cámara V
    Breast Cancer Res Treat; 2020 Jun; 181(2):339-345. PubMed ID: 32253684
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
    Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
    Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.
    Banerjee SM; Williams NR; Davidson TI; El Sheikh S; Tran-Dang M; Davison S; Ghosh D; Keshtgar MR
    Eur J Surg Oncol; 2016 May; 42(5):641-9. PubMed ID: 26979647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.